INTERNATIONAL PATENT: REMEGEN CO., LTD. FILES APPLICATION FOR "METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES"

GENEVA, March 24 -- REMEGEN CO., LTD. (No. 58 Beijing Middle Road, Yantai Development Zone, Yantai District, China (Shandong) Pilot Free Trade ZoneYantai, Shandong 264006) filed a patent application (PCT/CN2024/110142) for "METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES" on Aug 06, 2024. With publication no. WO/2025/055598, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FANG, Jianmin (No. 58 Beijing Middle Road, Yantai Development Zone, Yantai District, China (Shandong) Pilot...